MPM
GILD icon

MBB Public Markets’s Gilead Sciences GILD Stock Holding History

MBB Public Markets’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,490
Closed -$276K – 217
2025
Q2 		$276K Sell
2,490
-547
-18% -$58.2K 0.03% 197
2025
Q1 		$340K Buy
+3,037
New +$313K 0.04% 55
2024
Q4 		– Sell
-4,500
Closed -$377K – 276
2024
Q3 		$377K Sell
4,500
-82,510
-95% -$6.3M 0.02% 104
2024
Q2 		$5.97M Buy
87,010
+77,575
+822% +$5.18M 0.12% 145
2024
Q1 		$691K Buy
+9,435
New +$726K 0.04% 122
2022
Q1 		– Sell
-10,207
Closed -$741K – 230
2021
Q4 		$741K Buy
+10,207
New +$703K 0.01% 175

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MBB Public Markets's GILD Position: Q3 2025 in Review

MBB Public Markets sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 2,490 shares — an estimated $276K sold.

MBB Public Markets first reported a position in GILD in Q4 2021 and held it in 6 quarters. The position peaked at $5.97M in Q2 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • MBB Public Markets reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 2,490 Gilead Sciences shares in Q3 2025, an estimated $276K.
  • MBB Public Markets first reported a position in Gilead Sciences in Q4 2021 and held it in 6 quarters.
  • MBB Public Markets's Gilead Sciences position peaked at $5.97M in Q2 2024.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.